Author

Kimberly A. Luddy

ORCID 0000-0002-5172-221XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alexander R.A. AndersoniD· 1 shared Bina DesaiiD· 1 shared Cliona O’FarrellyiD· 1 shared Jacintha N O'SullivaniD· 1 shared Jeffrey WestiD· 1 shared Joel S. BrowniD· 1 shared Laure H. MarignoliD· 1 shared Mark Robertson‐TessiiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexander R.A. AndersonORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintMar 11, 2024

Evolutionary double-bind treatment using radiotherapy and NK cell-based immunotherapy in prostate cancer

Kimberly A. Luddy, Jeffrey West, Mark Robertson‐Tessi…·Cliona O’Farrelly

This study combines radiotherapy and NK cell immunotherapy to exploit an evolutionary double-bind strategy in prostate cancer, showing that RT-resistant cells become more vulnerable to NK cell killing.

5 citations

humanbulk RNA-seq

𝕏 PostBluesky